Explore This Program


The Division of Pediatric Hematology and Oncology is a comprehensive children's program backed by the full resources of Massachusetts General Hospital and close collaboration with adult colleagues in the Cancer Center. Doctors who specialize in the care of children provide personalized, state-of-the-art care to children of all ages with malignancies and disorders of the blood.

The Pediatric Hematology Program offers specialized expertise in anemias, including sickle cell disease, thrombocytopenia, neutropenia, aplastic anemia and other bone marrow failure syndromes. We also offer expert consultation and management of bleeding and clotting disorders including von Willebrand disease, hemophilia, thrombosis and stroke.

The Pediatric Oncology Program offers multidisciplinary, comprehensive and family centered care to children with all types of cancer. Our clinical staff has expertise in treating leukemias, lymphomas, common solid tumors of childhood including Wilms tumor, neuroblastoma, bone and soft tissue sarcomas, retinoblastoma, and brain tumors.

A Coordinated Multidisciplinary Approach

The patient care team is led by a pediatric hematologist-oncologist. Depending on the type of tumor and treatment plan, other members of the team may include a surgical specialist in pediatric surgery, thoracic surgery, neurosurgery, urology, otolaryngology, orthopedics, orthopedic oncology, ophthalmology, oculoplastics or plastic surgery. Patient considered for radiation therapy (proton beam, intensity modulated or other types) are evaluated by pediatric radiation oncologists. Our team also includes senior-level oncology-certified nurses, nurse practitioners, child psychiatrists, social workers, child life specialists, nutritionists, physical therapists and rehabilitation medicine specialists.

Patient Resources

View the full collection of patient resources from Pediatric Hematology and Oncology at MGfC

Active Clinical Research Program Ensures State-of-the-Art Treatment

Our patients have access to the latest clinical trials available in cancer research and hematology. We are members of the Children's Oncology Group (COG). Learn more about the Children's Oncology Group and childhood cancer.

Laboratory research is currently focusing on the molecular pathogenesis of malignancy and the interaction of blood vessels and platelets.